v3.26.1
Note 18- Related Parties (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 26, 2026
Dec. 31, 2025
Jun. 02, 2025
Jan. 29, 2025
Jan. 06, 2025
Oct. 28, 2024
Sep. 03, 2024
May 01, 2024
Jan. 09, 2023
Apr. 30, 2025
Mar. 31, 2026
Dec. 31, 2025
Jul. 11, 2025
Jun. 20, 2025
Feb. 28, 2025
Aug. 23, 2024
Aug. 22, 2024
Jul. 25, 2024
May 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period (in shares)     13,154                                
Class of Warrant or Right, Issued in Period (in shares)                     0                
Class of Warrant or Right, Exercised in Period (in shares)                     225,564                
Cardionomix Inc. [Member]                                      
Subsidiary, Ownership Percentage, Parent                     82.00%       82.00%        
KardioNav, Inc. [Member]                                      
Subsidiary, Ownership Percentage, Parent   57.00%                   57.00%   57.00%          
KardioNav, Inc. [Member] | Chelak iECG, Inc. [Member]                                      
Subsidiary, Ownership Percentage, Parent                           33.00%          
Series M Warrants [Member]                                      
Class of Warrant or Right, Issued in Period (in shares)   340,000                                  
Warrants and Rights Outstanding   $ 509,000                   $ 509,000              
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)                     $ 1.56                
Non-plan Options [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)                     0                
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period (in shares)     1,315                                
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number (in shares)   26,315                 26,315 26,315              
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in dollars per share)   $ 10.07                 $ 10.07 $ 10.07              
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)                     $ 0                
Share-Based Payment Arrangement, Option [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)                     200,000                
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number (in shares)   123,678                 318,985 123,678              
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in dollars per share)   $ 8.07                 $ 3.72 $ 8.07              
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)                     $ 1.15                
Chief Commercial Officer [Member] | Non-plan Options [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)       13,154       1,315                      
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)       $ 7.98       $ 101.1                      
Chief Commercial Officer [Member] | Share-Based Payment Arrangement, Tranche Two [Member] | Non-plan Options [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)       1,315                              
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)       4 years                              
Chief Commercial Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member] | Non-plan Options [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)       1,315                              
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage               20.00%                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)               5 years                      
Chief Commercial Officer [Member] | Share-Based Payment Arrangement, Tranche Three [Member] | Non-plan Options [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)       1,644                              
Chief Financial Officer [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)         26,315                            
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)         $ 10.07                            
Chief Financial Officer [Member] | Non-plan Options [Member]                                      
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)         $ 10.07                            
Chief Financial Officer [Member] | Share-Based Payment Arrangement, Option [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)         36 months                            
Chief Financial Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member] | Non-plan Options [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)         3 years                            
Jenkins and Chief Financial Officer [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) 40,000                                    
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share) $ 1.15                                    
Old Catheter [Member] | Mr. Jenkins and Affiliates [Member]                                      
Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares (in shares)                       1,325.838              
Old Catheter [Member] | Mr. Jenkins Adult Children [Member]                                      
Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares (in shares)                       1,284.344              
Conversion of Royalties Payable into Series J Preferred Stock [Member] | Inventor of LockeT [Member]                                      
Conversion of Stock, Shares Issued (in shares)   9,490                                  
LockeT Royalty [Member] | Inventor of LockeT [Member]                                      
Royalty Percentage                   5.00%                  
Royalty Guarantees, Commitments, Amount                   $ 1,000,000                  
LockeT Royalty [Member] | Royalty Payment After U.S. Patent Granted and One Million Paid [Member] | Inventor of LockeT [Member]                                      
Royalty Percentage                 2.00%                    
Royalty Guarantees, Commitments, Amount                   10,000,000                  
David Jenkins [Member]                                      
Convertible Notes Payable                 $ 25,100,000                    
Interest Accrued and Unpaid, Forgiven Amount                 $ 13,900,000                    
David Jenkins [Member] | LockeT Royalty [Member]                                      
Royalty Percentage                 12.00%                    
David Jenkins [Member] | Conversion of Convertible Promissory Notes into Series X Preferred Stock [Member]                                      
Convertible Preferred Stock, Shares Issued upon Conversion (in shares)                 7,856.251                    
Auston Locke [Member] | LockeT Royalty [Member]                                      
Royalty Percentage                 5.00%                    
Royalty Guarantees, Commitments, Amount                 $ 1,000,000 $ 1,000,000                  
Auston Locke [Member] | LockeT Royalty [Member] | Royalty Payment After U.S. Patent Granted and One Million Paid [Member]                                      
Royalty Percentage                   5.00%                  
Royalty Guarantees, Commitments, Amount                   $ 10,000,000                  
Increase in Royalty Percentage                   2.00%                  
Non-Executive Chief Operating Officer [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)                       757              
Non-Executive Chief Operating Officer [Member] | Share-Based Payment Arrangement, Tranche Two [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period (in shares)                       17              
Non-Executive Chief Operating Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number (in shares)   740                   740              
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in dollars per share)   $ 112.1                   $ 112.1              
Related Party [Member] | Related Party Notes [Member]                                      
Debt Instrument, Interest Rate, Stated Percentage                         4.20%     12.00% 8.00%    
Debt Instrument, Face Amount                         $ 150,000            
Related Party [Member] | Related Party Notes [Member] | Series M Warrants [Member]                                      
Class of Warrant or Right, Issued in Period (in shares)   170,000                                  
Jenkins Family Charitable Institute [Member]                                      
Debt Instrument, Face Amount                     $ 500,000                
Proceeds from Issuance Initial Public Offering             $ 500,000                        
Stock Issued During Period, Shares, New Issues (in shares)             13,947                        
Jenkins Family Charitable Institute [Member] | Prefunded Warrants [Member]                                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)             12,368                        
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)             $ 0.0019                        
Class of Warrant or Right, Exercised in Period (in shares)           12,368                          
Stock Issued During Period, Shares, Warrant Exercises (in shares)           12,368                          
Jenkins Family Charitable Institute [Member] | Series H Warrants [Member]                                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)             26,316                        
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)             $ 19                        
Jenkins Family Charitable Institute [Member] | Series I Warrants [Member]                                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)             26,316                        
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)             $ 19                        
Jenkins Family Charitable Institute [Member] | Series J Warrants [Member]                                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)             26,316                        
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)             $ 19                        
Class of Warrant or Right, Distributed (in shares)           23,684                          
Jenkins Family Charitable Institute [Member] | Related Party Notes [Member]                                      
Debt Instrument, Face Amount                                   $ 500,000  
Mr. Jenkins [Member]                                      
Debt Instrument, Face Amount                     $ 500,000                
Mr. Jenkins [Member] | Cardionomix Inc. [Member]                                      
Subsidiary, Ownership Percentage, Parent                           3.00% 5.00%        
Mr. Jenkins [Member] | Related Party Notes [Member]                                      
Debt Instrument, Face Amount                                     $ 500,000
Mr. Jenkins and Affiliates [Member] | Cardionomix Inc. [Member]                                      
Subsidiary, Ownership Percentage, Parent                           7.00% 7.00%        
Certain Third Parties [Member] | Cardionomix Inc. [Member]                                      
Subsidiary, Ownership Percentage, Parent                             6.00%